NCT04458142

Brief Summary

Everyday practice in dentistry is based on giving the painless injection and achieving adequate local anesthesia. Various techniques of reducing injection pain in children can be broadly categorized as psychological and physical. The psychological approach includes behavior management techniques, physical means and other recent techniques such as computer controlled anesthesia, electronic dental anesthesia, and so forth. However, none of these techniques have been successful in eliminating pain, fear and anxiety in children. Direct palatal injection technique is difficult to administer without significant pain or discomfort since there is little tissue space at these sites between the mucosa and the underlying periosteum. Studies conducted on indirect palatal injection technique (intrapapillary) revealed that it reduces the pain of palatal injection with the same efficacy of anesthesia during extraction. The desirable method to evade pain during palatal injection is just not to have one. Maxillary molars removal without palatal or multiple injections is possible due to relatively thin porous bone of posterior buccal maxilla that facilitates the diffusion of local anesthetic.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

July 7, 2020

Status Verified

July 1, 2020

Enrollment Period

5 months

First QC Date

June 30, 2020

Last Update Submit

July 1, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Behavior pain assessment during anesthesia and extraction

    FLACC Behavioral Pain Scale will be used for assessment during anaesthesia and extraction. This scale consists of 5 categories face, leg, activity, cry, consolabilty. Each category is scored on the 0-2 scale, which results in a total score of 0-10.

    Intraoperative

  • Subjective self report pain assessment after anesthesia and extraction

    Second subjective self report assesment will be done using Wong-baker scale after the anaesthsia and extraction.It consist of a set of cartoon faces with varying facial expression ranging from smile/laughter to tears.• Each face has a numerical value ranging from 0-5.

    intraoperative

  • physiological record of pain after anesthesia and extraction

    phisiological record including heart rate and blood pressure using an automatic blood pressure monitor.

    intraoperative

Study Arms (2)

Single buccal infiltration using 4%articaine

EXPERIMENTAL

Dryness the site of injection then application of topical anesthetic gel(2% benzocaine). Injecting by a small amount of solution in the superficial mucosa. After a few seconds, the needle was slowly advanced in the mucobuccal fold toward the apex of the molar and 1.8 ml of 4% articaine using short 30-gauge needle was slowly given. Subjective assessment of buccal and palatal soft tissue anesthesia will be assessed by inquiring about the area of numbness from the participant, no pain during pricking the palatal mucosa. The cases in which palatal anesthesia will not be reported by the patient will be given supplemental palatal infiltration with 0.2 to 0.3 mL articaine. After achieving adequate buccal and palatal tissue anesthesia, the tooth will be extracted under aspetic technique.

Other: Single buccal infiltration

Buccal and intrapapillary infiltration using 4%articaine

ACTIVE COMPARATOR

Dryness the site of injection then application of topical anesthetic gel(2% benzocaine) Injecting a small amount of solution in the superficial mucosa,then needle will slowly advanced in the mucobuccal fold toward the apex of the molar and 1.5 ml of 4% articaine was slowly given. The remaining 0.3ml solution will be given equally into the distal, mesial intrapapillary and palatal sites respectively until blanching of the palate is observed extending more than halfway along the palatal gingival margin. Subjective assessment of buccal and palatal soft tissue anesthesia will be assessed. After achieving adequate buccal and palatal tissue anesthesia, the tooth will be extracted under aspetic technique.

Other: Single buccal infiltration

Interventions

painless technique for palatal anesthesia,single injection,single puncture given

Buccal and intrapapillary infiltration using 4%articaineSingle buccal infiltration using 4%articaine

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children from 6 to 9 years of age requiring extraction in two different quadrants in maxillary arch.
  • Children who demonstrate positive or definitely positive behavior during pretreatment evaluation ranking 3 or 4 in the Frankl scale.
  • Rating 3: Positive Acceptance of treatment; at times cautious; willingness to comply with the dentist, at times with reservation, but patient follows the dentist's directions cooperatively.
  • Rating 4 :Definitely positive Good rapport with the dentists interested in the dental procedures, laughing and enjoying.
  • Child must give assent prior to participation, as well as parental informed written consent.

You may not qualify if:

  • Medically and mentally compromised children.
  • Children with a history of prolonged bleeding, platelet disorders, hypersensitivity,
  • History of significant behavior management problems.
  • Patients having active sites of pathosis in the area of injection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

June 30, 2020

First Posted

July 7, 2020

Study Start

October 1, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

July 7, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

study protocol, informed consent, clinical study report

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
After completion of the study
Access Criteria
ClinicalTrials.gov
More information